Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
15th National Conference of the IAOMFP, Chennai, 2006
Abstract
Abstracts from current literature
Acne in India: Guidelines for management - IAA Consensus Document
Addendum
Announcement
Art & Psychiatry
Article
Articles
Association Activities
Association Notes
Award Article
Book Review
Brief Report
Case Analysis
Case Letter
Case Letters
Case Notes
Case Report
Case Reports
Clinical and Laboratory Investigations
Clinical Article
Clinical Studies
Clinical Study
Commentary
Conference Oration
Conference Summary
Continuing Medical Education
Correspondence
Corrigendum
Cosmetic Dermatology
Cosmetology
Current Best Evidence
Current View
Derma Quest
Dermato Surgery
Dermatopathology
Dermatosurgery Specials
Dispensing Pearl
Do you know?
Drug Dialogues
e-IJDVL
Editor Speaks
Editorial
Editorial Remarks
Editorial Report
Editorial Report - 2007
Editorial report for 2004-2005
Errata
Erratum
Focus
Fourth All India Conference Programme
From Our Book Shelf
From the Desk of Chief Editor
General
Get Set for Net
Get set for the net
Guest Article
Guest Editorial
History
How I Manage?
IADVL Announcement
IADVL Announcements
IJDVL Awards
IJDVL AWARDS 2015
IJDVL Awards 2018
IJDVL Awards 2019
IJDVL Awards 2020
IJDVL International Awards 2018
Images in Clinical Practice
In Memorium
Inaugural Address
Index
Knowledge From World Contemporaries
Leprosy Section
Letter in Response to Previous Publication
Letter to Editor
Letter to the Editor
Letter to the Editor - Case Letter
Letter to the Editor - Letter in Response to Published Article
LETTER TO THE EDITOR - LETTERS IN RESPONSE TO PUBLISHED ARTICLES
Letter to the Editor - Observation Letter
Letter to the Editor - Study Letter
Letter to the Editor - Therapy Letter
Letter to the Editor: Articles in Response to Previously Published Articles
Letters in Response to Previous Publication
Letters to the Editor
Letters to the Editor - Letter in Response to Previously Published Articles
Letters to the Editor: Case Letters
Letters to the Editor: Letters in Response to Previously Published Articles
Medicolegal Window
Messages
Miscellaneous Letter
Musings
Net Case
Net case report
Net Image
Net Letter
Net Quiz
Net Study
New Preparations
News
News & Views
Obituary
Observation Letter
Observation Letters
Oration
Original Article
ORIGINAL CONTRIBUTION
Original Contributions
Pattern of Skin Diseases
Pearls
Pediatric Dermatology
Pediatric Rounds
Perspective
Presedential Address
Presidential Address
Presidents Remarks
Quiz
Recommendations
Regret
Report
Report of chief editor
Report of Hon : Treasurer IADVL
Report of Hon. General Secretary IADVL
Research Methdology
Research Methodology
Resident page
Resident's Page
Resident’s Page
Residents' Corner
Residents' Corner
Residents' Page
Retraction
Review
Review Article
Review Articles
Revision Corner
Self Assessment Programme
SEMINAR
Seminar: Chronic Arsenicosis in India
Seminar: HIV Infection
Short Communication
Short Communications
Short Report
Special Article
Specialty Interface
Studies
Study Letter
Supplement-Photoprotection
Supplement-Psoriasis
Symposium - Contact Dermatitis
Symposium - Lasers
Symposium - Pediatric Dermatoses
Symposium - Psoriasis
Symposium - Vesicobullous Disorders
SYMPOSIUM - VITILIGO
Symposium Aesthetic Surgery
Symposium Dermatopathology
Symposium-Hair Disorders
Symposium-Nails Part I
Symposium-Nails-Part II
Systematic Reviews and Meta-analysis
Tables
Technology
Therapeutic Guidelines
Therapeutic Guidelines - IADVL
Therapeutics
Therapy
Therapy Letter
View Point
Viewpoint
What’s new in Dermatology
View/Download PDF

Translate this page into:

Letter to the Editor - Study Letter
2019:85:6;653-655
doi: 10.4103/ijdvl.IJDVL_741_18
PMID: 31552837

Aberrant expression of bradykinin b2 receptor in the epidermis of patients with psoriasis vulgaris

Haibo Liu1 , Min Zhang2 , Xiaoping Dong1 , Fang Liu1 , Hong Sang1
1 Department of Dermatology, Jinling Hospital, Nanjing University, School of Medicine, Nanjing, 210002, People's Republic of China
2 Department of Dermatology, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, 211100, People's Republic of China

Correspondence Address:
Hong Sang
Department of Dermatology, Jinling Hospital, Nanjing University, School of Medicine, Nanjing, 210002
People's Republic of China
How to cite this article:
Liu H, Zhang M, Dong X, Liu F, Sang H. Aberrant expression of bradykinin b2 receptor in the epidermis of patients with psoriasis vulgaris. Indian J Dermatol Venereol Leprol 2019;85:653-655
Copyright: (C)2019 Indian Journal of Dermatology, Venereology, and Leprology

Sir,

A constant serine protease activity is crucial for steady desquamation and the function of skin barrier.[1] The human tissue kallikrein gene family encodes for 15 secretory serine proteases responsible for the steady desquamation of corneocytes.[1] The psoriatic epidermis contains high levels of all kallikreins.[2] The kallikreins levels in the stratum corneum and serum of patients with psoriasis are dependent on the severity and phenotype of psoriasis.[2] Tissue kallikrein (encoded by kallikrein 1 gene) functions as a serine protease and is capable of liberating kinin peptides from kininogens by enzymatic reaction. The released kinins exhibit a wide variety of effects by activating kinin b1 and b2 receptors (b1r and b2r).[3] It is unknown whether the downstream receptors of kinin are expressed in skin lesions of psoriasis vulgaris.

Envision methods were used for immunohistochemical staining. The normal tissue and chronic plaque psoriatic lesions were stained with antibodies specific for human b1r (Biorbyt, Cambridge, UK) and human b2r (BD Biosciences, USA). B1r was expressed at a level comparable to b2r in positive controls. Normal human skin samples were obtained from six volunteers (two females and four males, 36.5 ± 10.5 years old). B1r was nearly undetected in the normal epidermis [Figure - 1]a and appendages , [Figure - 1]b, [Figure - 1]c, [Figure - 1]d, [Figure - 1]e. In contrast, b2r was immunohistochemically detected in the stratum granulosum, stratum spinosum, and stratum basale of normal epidermis [Figure - 1]a. No expression of b2r was observed in the stratum corneum [Figure - 1]a. B2r showed diffuse staining and the intensity of b2r expression was much higher in the nucleus than that in the cytoplasm [Figure - 1]a. The skin appendages, with the exception of intradermal sensory nerves, showe distribution of b2r, specifically [Figure - 1]b, [Figure - 1]c, [Figure - 1]d, [Figure - 1]e. We obtained chronic plaque lesions of psoriasis vulgaris from six patients (three females and three males, 39.0 ± 7.3 years old), who were free of any medication. In psoriasis vulgaris, b1r was nearly undetected in the psoriatic epidermis and appendages [Figure - 2]a, [Figure - 2]b, [Figure - 2]c, [Figure - 2]d. In contrast, b2r expression was intense, and it was detected in the stratum granulosum, stratum spinosum, and stratum basale [Figure - 2]a. The appendages, with the exception of intradermal sensory nerves, also showed specific distribution of b2r [Figure - 2]b, [Figure - 2]c, [Figure - 2]d. In the cells of psoriatic epidermis, b2r showed diffuse cytoplasmic staining, but it showed a granular staining in the nucleus [Figure - 2]a. Moreover, the intensity of b2r expression was lower in the cells of psoriatic epidermis than that in the cells of normal epidermis, and cells in the psoriatic epidermis were frequently negative for cytoplasmic or nuclear staining [Figure - 2]a. In psoriatic lesions and the adjacent skin, b1r was not detected [Figure - 3]a. In contrast, b2r was detected both in psoriatic lesion and in its adjacent skin, and the number of cell layers expressing b2r was increased in psoriatic lesions compared to that in the adjacent skin [Figure - 3]b and [Figure - 3]c. However, the intensity of b2r expression was lower in the psoriatic epidermis than that in its adjacent skin [Figure - 3]b and [Figure - 3]c. B2r expression gradually decreased depending on the epidermal thickness [Figure - 3]b and [Figure - 3]c. We scored both the staining intensity (negative = 0, weak = 1, moderate = 2, and strong = 3) and the proportion (0%–5% =0, 6%–25% =1, 26%–50% =2, 51%–75% =3, 76%–100% =4) of positive cells and then calculated the final score by multiplying the intensity and the proportion scores. Analysis of b2r scores revealed that the mean score of stratum granulosum decreased from 8.73 ± 2.15 in adjacent skin to 4.47 ± 2.26 in psoriatic skin (P < 0.001). Similarly, the mean score of staining in the stratum spinosum decreased from 10.6 ± 1.80 in adjacent skin to 4.93 ± 1.49 in psoriatic skin (P < 0.001). However, there was no significant difference in the mean score of stratum basale staining between adjacent skin (6.80 ± 1.66) and psoriatic skin (5.73 ± 1.83) (P = 0.105).

Figure 1:
Figure 2:
Figure 3:

Although b1r may amplify and play a dominant role in chronic inflammation processes, the involvement of b1r in the pathogenesis of psoriasis seems to be excluded, due to the absence of expression of b1r in both normal skin and chronic plaque lesions of psoriasis vulgaris.[4] Results from a previous study suggest a protective role of b2r in ischemic injury.[5] Kallikrein, by acting on b2r, reduces ischemia-reperfusion-induced apoptosis of neuronal cells and inhibits inflammatory cell accumulation in the ischemic brain.[5] The decreased expression of b2r in chronic plaque lesions of psoriasis vulgaris indicates a protective role of b2r. Moreover, the intensity of b2r expression was dependent on the epidermal thickness, suggesting the implication of b2r in the pathogenesis of psoriasis. B2r may serve as candidate target for the diagnosis and treatment of psoriasis. However, further studies are needed to explore this hypothesis.

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms. In the form the patients have given their consent for their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.

Financial support and sponsorship

This work was supported by funding from China Postdoctoral Science Foundation Grant (2015T81134) and National Natural Science Foundation of China (81501729).

Conflicts of interest

There are no conflicts of interest.

References
1.
Komatsu N, Saijoh K, Toyama T, Ohka R, Otsuki N, Hussack G, et al. Multiple tissue kallikrein mRNA and protein expression in normal skin and skin diseases. Br J Dermatol 2005;153:274-81.
[Google Scholar]
2.
Komatsu N, Saijoh K, Kuk C, Shirasaki F, Takehara K, Diamandis EP. Aberrant human tissue kallikrein levels in the stratum corneum and serum of patients with psoriasis: Dependence on phenotype, severity and therapy. Br J Dermatol 2007;156:875-83.
[Google Scholar]
3.
Chao J, Chao L. Kallikrein-kinin in stroke, cardiovascular and renal disease. Exp Physiol 2005;90:291-8.
[Google Scholar]
4.
Ahluwalia A, Perretti M. B1 receptors as a new inflammatory target. Could this B the 1? Trends Pharmacol Sci 1999;20:100-4.
[Google Scholar]
5.
Xia CF, Yin H, Yao YY, Borlongan CV, Chao L, Chao J. Kallikrein protects against ischemic stroke by inhibiting apoptosis and inflammation and promoting angiogenesis and neurogenesis. Hum Gene Ther 2006;17:206-19.
[Google Scholar]

Fulltext Views
504

PDF downloads
126
Show Sections